Disclosed positions

Estimated from their latest filings — positions may have changed since

$8.26M

combined est. value

Stock	Shares	Price	Value	Weight	As of
OLMAOlema Pharmaceuticals, Inc.	687,607	$12.01	$8.26M	100%	2026-01-14

OLMA

Olema Pharmaceuticals, Inc.

$8.26M

687,607 sh

All filings on record

Every Form 4 transaction we track for this filer

all 11buys 0sells 8

Stock	Transaction	Date	~6mo later
OLMAOlema Pharmaceuticals, Inc.	Sell $1.01M · 35,003 sh	2026-01-14	—
OLMAOlema Pharmaceuticals, Inc.	Sell $428.9K · 14,997 sh	2026-01-14	—
OLMAOlema Pharmaceuticals, Inc.	Exercise $243.5K · 50,000 sh	2026-01-14	—
OLMAOlema Pharmaceuticals, Inc.	Sell $5.7K · 200 sh	2026-01-13	—
OLMAOlema Pharmaceuticals, Inc.	Sell $1.37M · 49,800 sh	2026-01-13	—
OLMAOlema Pharmaceuticals, Inc.	Exercise $243.5K · 50,000 sh	2026-01-13	—
OLMAOlema Pharmaceuticals, Inc.	Sell $283.4K · 10,000 sh	2026-01-12	—
OLMAOlema Pharmaceuticals, Inc.	Gift — · 9,000 sh	2025-12-19	—
OLMAOlema Pharmaceuticals, Inc.	Sell $189.8K · 6,046 sh	2025-12-19	—
OLMAOlema Pharmaceuticals, Inc.	Sell $1.33M · 43,729 sh	2025-12-19	—
OLMAOlema Pharmaceuticals, Inc.	Sell $34.4K · 1,225 sh	2025-12-19	—

OLMASell

2026-01-14 · Olema Pharmaceuticals, Inc.

$1.01M

—

OLMASell

2026-01-14 · Olema Pharmaceuticals, Inc.

$428.9K

—

OLMAExercise

2026-01-14 · Olema Pharmaceuticals, Inc.

$243.5K

—

OLMASell

2026-01-13 · Olema Pharmaceuticals, Inc.

$5.7K

—

OLMASell

2026-01-13 · Olema Pharmaceuticals, Inc.

$1.37M

—

OLMAExercise

2026-01-13 · Olema Pharmaceuticals, Inc.

$243.5K

—

OLMASell

2026-01-12 · Olema Pharmaceuticals, Inc.

$283.4K

—

OLMAGift

2025-12-19 · Olema Pharmaceuticals, Inc.

9,000

—

OLMASell

2025-12-19 · Olema Pharmaceuticals, Inc.

$189.8K

—

OLMASell

2025-12-19 · Olema Pharmaceuticals, Inc.

$1.33M

—

OLMASell

2025-12-19 · Olema Pharmaceuticals, Inc.

$34.4K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.